DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo

4.15 0.07 (1.72%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

THLD $4.15 1.72%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.11
Previous Close $4.08
Daily Range $4.05 - $4.17
52-Week Range $3.51 - $5.93
Market Cap $246.4M
P/E Ratio -11.66
Dividend (Yield) $0.00 (0.0%)
Volume 163,772
Average Daily Volume 364,350
Current FY EPS -$0.52

Sector

Healthcare

Industry

Drugs

THRESHOLD PHARMACEUTICALS, INC. (THLD) Description

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer. Website: http://www.thresholdpharm.com/

News & Commentary Rss Feed

3 Stocks Near 52-Week Lows Worth Buying

Do Westport Innovations, Threshold Pharmaceuticals, and and Rowan Cos. deserve a second chance? You be the judge!

Clinical Trial Results To Watch

Biotech Stock Mailbag: Threshold, Galena, CytRx

5 Stocks Ready for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

Threshold Announces Initiation Of Dosing With TH-302/Bortezomib In Final Stage Of Ongoing Phase 1/2

Threshold Announces Initiation Of Dosing With TH-302/Bortezomib In Final Stage Of Ongoing Phase 1/2 Trial Of Patients With Relapsed/Refractory Multiple Myeloma

Threshold Initiates Phase 2 Clinical Trial In Advanced Non-Squamous Non-Small Cell Lung Cancer

Threshold Pharmaceuticals Presents A Robust Risk/Reward As A Speculative Small-Cap Cancer Investment

Sector Update: Healthcare Shares Mixed Pre-Market; Pfizer Sinks 3% on Results of Breast Cancer Treat

Sector Update: Healthcare Shares Mixed Pre-Market; Pfizer Sinks 3% on Results of Breast Cancer Treatment Study

3 Biotechnology Stocks Poised For Future Growth

See More THLD News...

THLD's Top Competitors

THLD $4.15 (1.72%)
Current stock: THLD
GILD $107.41 (1.07%)
Current stock: GILD
CELG $94.74 (-0.96%)
Current stock: CELG
BIIB $343.36 (0.11%)
Current stock: BIIB